Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

Real-time Quote. Real-time Tradegate - 08/26 10:25:06 am
68.22 EUR   -0.51%
08/25 DÉPAKINE : 14 300 femmes enceintes seront indemnisées
08/24 SANOFI : Haiti Impact Trip Provides Eye-Opening Experience for Stop ..
08/22 MEDIVATION : Pfizer propose 14 milliards de dollars pour racheter Me..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Sanofi to Cut 1,500-2,000 Jobs in France - Report

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/15/2012 | 02:11pm CEST

French pharmaceutical giant Sanofi SA (SAN.FR, SNY) will disclose cuts of between 1,500 and 2,000 jobs in France on Sept. 25, French newspaper Le Figaro reported Saturday, without citing sources.

The company plans to reduce its 28,000 payroll in France mainly through attrition, the newspaper said.

In July, Sanofi had said it planned to cut jobs at two French units in a bid to preserve the company's profitability, which has been put at risk by recent patent expirations and the economic recession in most of Europe. The company had said it would detail the job cuts in September.

At the time, French Industry Minister Arnaud Montebourg had criticized the company and said he wouldn't tolerate when profitable companies slash jobs.

A Sanofi spokesman didn't return a phone call seeking comments.

Newspaper Web site: http://www.lefigaro.fr

Write to Inti Landauro at inti.landauro@dowjones.com.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SANOFI
08/25 SANOFI : Researchers from Sanofi Aventis Report Findings in Hepatic Encephalopat..
08/25 DÉPAKINE : 14 300 femmes enceintes seront indemnisées
08/24 SANOFI : Haiti Impact Trip Provides Eye-Opening Experience for Stop Hunger Now P..
08/22 MEDIVATION : Pfizer propose 14 milliards de dollars pour racheter Medivation
08/22 Pfizer to buy cancer drugmaker Medivation for $14 billion
08/22 Pfizer to buy Medivation and boost cancer drug portfolio
08/22 SANOFI : Provides Update on New Drug Application for Investigational Once-Daily ..
08/22 PHARMA MAJOR PFIZER OUTBIDS SANOFI T : Reports
08/22DJPfizer Near $14 Billion Deal for Biotech -- WSJ
08/21 SANOFI : Research center in Oro Valley looks to grow after spinoff from Sanofi
More news
Sector news : Pharmaceuticals - NEC
08/25 FTSE retreats as pharma stocks fall
08/25DJStocks Fall as Investors Look to Fed's Jackson Hole Meeting
08/25DJStocks Fall as Investors Look to Fed's Jackson Hole Meeting
08/25DJStocks Fall as Investors Look to Fed's Jackson Hole Meeting -- 3rd Update
08/25DJMylan Boosts Price Assistance for EpiPen Amid Backlash
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
08/25 Shocked! Mylan, Biotechs Swoon After Hillary's Statement
08/25 IBB And The Drug Pricing Issue
08/24 PFIZER-MEDIVATION DEAL : Good Or Bad For Shareholders?
08/23 Who's Next After Medivation?
08/22 FDA OK of Sanofi's type 2 diabetes med iGlarLixi pushed out to November
Advertisement
Financials (€)
Sales 2016 36 960 M
EBIT 2016 9 286 M
Net income 2016 5 309 M
Debt 2016 5 008 M
Yield 2016 4,30%
P/E ratio 2016 15,66
P/E ratio 2017 14,26
EV / Sales 2016 2,53x
EV / Sales 2017 2,53x
Capitalization 88 387 M
More Financials
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 23
Average target price 84,5 €
Spread / Average Target 23%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
JÚr˘me Contamine Chief Financial Officer & EVP-Finance
Elias E. Zerhouni President-Global Research & Development
Yong-Jun Liu Head-Global Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI-12.76%100 405
JOHNSON & JOHNSON15.43%324 776
ROCHE HOLDING LTD.-11.47%217 694
NOVARTIS AG-9.62%213 882
PFIZER INC.7.71%211 206
MERCK & CO., INC.17.99%173 462
More Results